Low dose steroids and clinical relapse in Crohn's disease: a controlled trial.
Open Access
- 1 July 1978
- Vol. 19 (7) , 606-610
- https://doi.org/10.1136/gut.19.7.606
Abstract
The long-term effect of prednisone in Crohn's disease has been examined in a double-blind controlled trial. Clinical relapse, recurrence, and extension of the disease were examined in 64 patients followed-up for up to three years. Fourteen patients were withdrawn because of severe symptoms (eight on prednisone and six controls); the withdrawal rate in both groups was 30% at three years. Nine other patients had radiological recurrence or extension of disease (five prednisone and four controls). Prednisone did not improve the relapse rate, nor did it affect recurrence or extension of disease.Keywords
This publication has 11 references indexed in Scilit:
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.1976
- A controlled trial of azathioprine in Crohn's diseaseDigestive Diseases and Sciences, 1975
- CONTROLLED TRIAL OF AZATHIOPRINE IN CROHN'S DISEASEPublished by Elsevier ,1971
- Recurrence of Crohn's disease after primary excisional surgeryGut, 1971
- Corticosteroid or corticotrophin therapy in Crohn's disease (regional enteritis)Gut, 1970
- Corticosteroids and corticotrophin in the treatment of Crohn's disease.Gut, 1966
- Nutritional and metabolic factors in the aetiology and treatment of regional ileitis; Hunterian lecture delivered at the Royal College of Surgeons of England on 28th April 1955.1955
- Regional enteritis.1954